You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2025

Details for Patent: 4,907,583


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,907,583
Title: Device in powder inhalators
Abstract:Device in a previously known powder inhalator intended for inhalation of an air flow which contains pharmacologically active compound in micronized form. The powder inhalator comprises a nozzle unit (2) with a nozzle aperture (2a) as well as a container unit (3) with a releasing or dosing unit (6) for delivering the active compound. The air flow generated by inhalation is at least partly aspirated through an air conduit (7) located in the container unit (3), which conduit extends from an air inlet (8), communicating with the environment, via said releasing or dosing unit (6), up to said nozzle unit (2). According to the invention, deflector devices are stationarily arranged in the container unit (3) and/or in the nozzle unit (2), said deflector devices, for example in the shape of a helical channel portion (13), being arranged to create a powerful deflecting movement for the purpose of disrupting said powder particles into the respirable particle size distribution (less than 5 .mu.m).
Inventor(s): Wetterlin; Kjell I. L. (S Sandby, SE), Virtanen; Risto (Nurmijarvi, FI), Andersson; Jan A. R. (S Sandby, SE)
Assignee: Aktiebolaget Draco (Lund, SE)
Application Number:07/287,611
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 4,907,583: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 4,907,583, assigned to Wetterlin, is a significant patent in the field of medical devices, specifically focusing on inhalation devices for delivering powdered medications. This patent is part of a series of inventions by Wetterlin that aimed to improve the design and functionality of inhalers.

Background

The patent landscape in the early 1990s saw a surge in innovations related to inhalation devices, driven by the need for more efficient and reliable delivery systems for powdered medications. Wetterlin's patents, including U.S. Patent 4,907,583, were pivotal in this development.

Scope of the Patent

Device Overview

The patent describes a dosage device designed for delivering a precise amount of powdered medicament to a patient. The device includes a storage chamber for holding the active compound, a perforated membrane, and a mechanism for introducing the active compound into the perforations of the membrane[1].

Key Components

  • Storage Chamber: This is where the powdered medicament is stored.
  • Perforated Membrane: This membrane is rotatably positioned under the storage chamber and has perforations where the active compound is introduced.
  • Scrapers and Spring Mechanism: Elastic, spring-loaded scrapers are used to introduce the active compound into the perforations of the membrane. A coil spring biases the scrapers into engagement with the membrane[1].

Claims

The patent claims are centered around the specific design and operation of the inhalation device. Here are some key claims:

Claim 1

The patent claims a dosage device that includes a storage chamber, a perforated membrane, and a scraper assembly. The membrane is movable between two positions: one where the active compound is introduced by the scrapers and another where the loaded membrane is inserted into the air conduit of the inhalator[1].

Claim 2

The device includes a ratchet mechanism to provide distinct positions for the perforated membrane when it is advanced by the base or maneuvering unit. This mechanism involves spring-loaded pins engaging the ratcheted bottom of the membrane[1].

Patent Landscape

Prior Art

The Wetterlin patents, including U.S. Patent 4,907,583, built upon existing designs but introduced significant improvements. Prior art, such as U.S. Patents 4,534,345 and 4,667,668, also by Wetterlin, involved more complex arrangements with multiple openings in a metering plate that required separate rotation from the main housing and a ratchet mechanism for indexing[1].

Comparison with Other Patents

  • Simplicity and Reliability: Unlike the prior art, the device described in U.S. Patent 4,907,583 is simpler in construction and assembly. It eliminates the need for a complex ratchet assembly by integrating the metering disk portion with the stationary body[1].
  • Innovation by Virtanen: U.S. Patent 4,668,218 by Virtanen, while similar to Wetterlin's designs, includes an indicating assembly to show the number of medicament dosages administered, adding an additional layer of functionality[1].

Impact on the Industry

The innovations presented in U.S. Patent 4,907,583 have had a lasting impact on the design of inhalation devices. Here are a few key points:

Simplified Design

The integration of the metering disk with the stationary body and the use of a single receptacle in the metering disk portion simplified the construction and assembly of the device, making it more reliable and less prone to breakage[1].

Cost Efficiency

By reducing the complexity of the indexing mechanism and eliminating the need for multiple openings in the metering plate, the device became less costly to manufacture and maintain[1].

User Experience

The design improvements made the device easier to use for patients, ensuring a more consistent and reliable delivery of powdered medications.

Criticisms and Limitations

Despite the innovations, the Wetterlin patents, including U.S. Patent 4,907,583, have been criticized for their complexity relative to some later designs. For example, later patents described simpler and more robust mechanisms that did not require a ratchet assembly or multiple openings in the metering plate[1].

Legacy and Current Status

Expiration and Public Domain

The patent has expired, and the technology is now in the public domain. This has allowed other manufacturers to build upon and improve the design without the need for licensing or royalties.

Influence on Modern Designs

The principles outlined in U.S. Patent 4,907,583 continue to influence modern inhalation device designs. Manufacturers have refined these concepts to create even more efficient and user-friendly devices.

Key Takeaways

  • Simplified Design: The patent introduced a simpler and more reliable design for inhalation devices.
  • Cost Efficiency: The device was less costly to manufacture and maintain compared to prior art.
  • Impact on Industry: The innovations had a lasting impact on the design of inhalation devices.
  • Legacy: The patent has expired, and its technology is now in the public domain.

FAQs

What is the main innovation of U.S. Patent 4,907,583?

The main innovation is the simplified design of the inhalation device, which integrates the metering disk with the stationary body and eliminates the need for a complex ratchet assembly.

How does the device deliver the powdered medicament?

The device uses elastic, spring-loaded scrapers to introduce the active compound into the perforations of a rotatable membrane, which is then inserted into the air conduit of the inhalator.

What are the key components of the device?

The key components include a storage chamber, a perforated membrane, and a scraper assembly with a spring mechanism.

How does the ratchet mechanism work?

The ratchet mechanism involves spring-loaded pins engaging the ratcheted bottom of the membrane to provide distinct positions for the perforated membrane.

Is the patent still in effect?

No, the patent has expired, and the technology is now in the public domain.

Cited Sources

  1. EP0520440B1 - Dispositif d'inhalation pour ... - Google Patents
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. Patent 2152088 Summary - Canadian Patents Database

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,907,583

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 4,907,583

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden86010600Mar 07, 1986

International Family Members for US Patent 4,907,583

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 601400 ⤷  Try for Free
Australia 6960487 ⤷  Try for Free
Austria 70720 ⤷  Try for Free
Canada 1276848 ⤷  Try for Free
Cyprus 1798 ⤷  Try for Free
Germany 237507 ⤷  Try for Free
Germany 3775433 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.